CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
22.29
-1.09 (-4.66%)
At close: Feb 21, 2025, 4:00 PM
22.18
-0.11 (-0.49%)
After-hours: Feb 21, 2025, 6:46 PM EST
CareDx Employees
As of December 31, 2023, CareDx had 643 total employees, including 635 full-time and 8 part-time employees. The number of employees decreased by 95 or -12.87% compared to the previous year.
Employees
643
Change (1Y)
-95
Growth (1Y)
-12.87%
Revenue / Employee
$486,431
Profits / Employee
-$223,263
Market Cap
1.20B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CDNA News
- 1 day ago - Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - Business Wire
- 2 days ago - CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients - Business Wire
- 9 days ago - CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies - Business Wire
- 11 days ago - CareDx to Report Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 5 weeks ago - CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results - Business Wire
- 2 months ago - CareDx: Top Of My Shopping List For 2025 - Seeking Alpha
- 2 months ago - CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - PRNewsWire